Want to see OKYO full AI Analyst Report?
OKYO Pharma Limited Sponsored ADR (OKYO) Stock Forecast & Price Target
OKYO Analyst Ratings
Moderate Buy
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to OKYO Pharma Limited Sponsored ADR in the past 3 months
OKYO Stock 12 Month Forecast
Average Price Target
$6.00▲(308.16% Upside)Based on 2 Wall Street analysts offering 12 month price targets for OKYO Pharma Limited Sponsored ADR in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 308.16% change from the last price of $1.47.
Past 12 Months12 Month ForecastJan2026Oct2026
High$7.00
Average$6.00
Low$5.00
Highest Price TargetHighest$7.00Average Price Target$6.00Lowest Price TargetLowest$5.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Yi Chen | H.C. Wainwright | $5 | buy | 240.14%Upside | Reiterated | 10/06/26 | ||
| Biren Amin | Piper Sandler | $7 | buy | 376.19%Upside | Reiterated | 08/27/26 | ||
| William Wood | B. Riley Securities | $5 | buy | 240.14%Upside | Initiated | 12/08/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Yi Chen | 10/06/26 | $5 | buy | 240.14%Upside | Reiterated | H.C. Wainwright | ||
| Biren Amin | 08/27/26 | $7 | buy | 376.19%Upside | Reiterated | Piper Sandler | ||
| William Wood | 12/08/25 | $5 | buy | 240.14%Upside | Initiated | B. Riley Securities |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering OKYO Pharma Limited Sponsored ADR
3 Months
Success Rate4/13 ratings generated profit
31%
Average Return
+5.18%
Copying Yi Chen's trades and holding each position for 3 Months would result in 30.77% of your transactions generating a profit, with an average return of +5.18% per trade.
1 Year
Success Rate6/13 ratings generated profit
46%
Average Return
+15.92%
Copying Yi Chen's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of +15.92% per trade.
2 Years
Success Rate6/13 ratings generated profit
46%
Average Return
-2.43%
Copying Yi Chen's trades and holding each position for 2 Years would result in 46.15% of your transactions generating a profit, with an average return of -2.43% per trade.
OKYO Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 2 | 2 | 2 | 1 |
In the current month, OKYO has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OKYO average Analyst price target in the past 3 months is 6.00.
OKYO Financial Forecast
OKYO Stock Forecast FAQ
What is OKYO’s average 12-month price target, according to analysts?
Based on analyst ratings, OKYO Pharma Limited Sponsored ADR’s 12-month average price target is $6.00.
What is OKYO’s upside potential, based on the analysts’ average price target?
OKYO Pharma Limited Sponsored ADR has 308.16% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is OKYO a Buy, Sell or Hold?
OKYO Pharma Limited Sponsored ADR has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is OKYO Pharma Limited Sponsored ADR’s price target?
The average price target for OKYO Pharma Limited Sponsored ADR is $6.00. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $7.00, the lowest forecast is $5.00. The average price target represents a 308.16% increase from the current price of $1.47.
What do analysts say about OKYO Pharma Limited Sponsored ADR?
OKYO Pharma Limited Sponsored ADR’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of OKYO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
